NCT03519737View on ClinicalTrials.gov

Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke

NAUnknownINTERVENTIONAL
Enrollment

596

Participants

Timeline

Start Date

August 17, 2018

Primary Completion Date

November 30, 2021

Study Completion Date

December 31, 2021

Conditions
Acute Ischemic Stroke
Interventions
DEVICE

tPA in combination with the Sonolysis Headframe (TUS)

tPA: 60 minutes per approved labeling TUS insonation via the Sonolysis Headframe: minimum 90 minutes - maximum 120 minutes

DEVICE

tPA in combination with the Sonolysis Headframe (Sham TUS)

tPA per approved labeling Sham (inactive) TUS insonation via the Sonolysis Headframe: minimum 90 minutes - maximum 120 minutes

Trial Locations (2)

38163

The University of Tennessee Health Science Center, Memphis

77030

Memorial Hermann Hospital - Texas Medical Center (TMC), Houston

Sponsors
All Listed Sponsors
lead

Cerevast Medical, Inc.

INDUSTRY

NCT03519737 - Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter